ASP2390 / Astellas 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ASP2390 / Astellas
NCT04184895: A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites

Active, not recruiting
1
28
Europe
ASP2390, Placebo
Astellas Pharma Global Development, Inc.
Allergic to House Dust Mites
12/22
12/26

Download Options